![Michael Amoroso](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Amoroso
Vorstandsvorsitzender bei
PRECISION BIOSCIENCES, INC.
Vermögen: 3 Mio $ am 31.05.2026
Profil
Michael Amoroso is President, Chief Executive Officer & Director at Precision BioSciences, Inc. since 2021.
Formerly, Mr. Amoroso was Chairman at Abeona Therapeutics, Inc. from 2021 to 2026, Senior Vice President-Americas at Eisai, Inc. from 2017 to 2018, and SVP & Head-Cell Therapy Worldwide Commercial at Kite Pharma, Inc. from 2018 to 2020.
Education includes undergraduate studies at Rider University and an MBA from The Leonard N Stern School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.06.2026 | 243’392 ( 1.01% ) | 2 Mio $ | 31.05.2026 | |
| 15.04.2026 | 217’779 ( 0.38% ) | 1 Mio $ | 31.05.2026 |
Aktive Positionen von Michael Amoroso
| Unternehmen | Position | Beginn |
|---|---|---|
| PRECISION BIOSCIENCES, INC. | Vorstandsvorsitzender | 15.10.2021 |
Ehemalige bekannte Positionen von Michael Amoroso
| Unternehmen | Position | Ende |
|---|---|---|
| ABEONA THERAPEUTICS INC. | Vorstandsvorsitzender | 14.10.2021 |
| KITE PHARMA INC | Corporate Officer/Principal | 01.01.2020 |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Corporate Officer/Principal | 01.08.2018 |
Ausbildung von Michael Amoroso
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
9
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Abeona Therapeutics, Inc.
 Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
Precision BioSciences, Inc.
 Precision BioSciences, Inc. BiotechnologyHealth Technology Develops technology to produce custom, genome-editing enzymes for human health and biological research | Health Technology |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Health Technology |
Rider University
 Rider University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kite Pharma, Inc.
 Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wählen Sie MarketScreener 
